Discussion
Treatment with the investigational drug efzofitimod — given by infusion once every four weeks — significantly improved general health and lung-related quality of life in adults with pulmonary sarcoidosis while also significantly easing fatigue and numerically reducing the use of oral corticosteroids. Lung function was also preserved among…